Bank of England Opens Door to Possible Rate Hike
BlockBeats News, March 19, the Bank of England on Thursday unanimously voted to keep interest rates unchanged, marking the first time in four and a half years that the Bank of England has made a decision without any members dissenting. The atmosphere of this meeting underwent a significant shift. The Middle East conflict disrupted production activities in the world's most important oil-producing region and led to disruptions in oil tanker shipments through the critical Strait of Hormuz. Rate-setters opened the door to a possible rate hike, with Governor Bailey warning that policy must "address the risks of potentially more persistent impacts on UK CPI."
In another statement, he added: "Whatever the outcome, our responsibility is to ensure that the inflation rate returns to the 2% target level." The Bank of England removed the reference from its February statement that "the base rate could be further reduced." The Bank of England's most dovish member, Tenreyro, said that if there is a prolonged energy supply crisis, it may be necessary to raise rates. Several rate-setters indicated that if the conflict did not escalate, they would have supported measures to lower borrowing costs. (FXStreet)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
